CDK4 Gene Melanoma Cutaneous Malignant Familial CDK4 Related Genetic Test
Introduction
At DNA Labs UAE, we offer the CDK4 Gene Melanoma Cutaneous Malignant Familial CDK4 Related Genetic Test to assess the risk of developing familial cutaneous malignant melanoma. This test analyzes the CDK4 gene, which is responsible for regulating cell cycle and has been associated with an increased risk of developing this type of skin cancer.
Test Details
The CDK4-related NGS genetic test utilizes next-generation sequencing technology to analyze the CDK4 gene for any mutations or variations. This high-throughput DNA sequencing technique allows us to simultaneously analyze multiple genes and identify any abnormalities that may be present.
Components and Price
The cost of the CDK4 Gene Melanoma Cutaneous Malignant Familial CDK4 Related Genetic Test is AED 4400.0. The test can be conducted using blood samples, extracted DNA, or even a single drop of blood on an FTA card.
Report Delivery
The results of the test are typically delivered within 3 to 4 weeks after sample submission.
Pre-Test Information
Before undergoing the CDK4 Gene Melanoma Cutaneous Malignant Familial CDK4 Related Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by CDK4 Gene Melanoma, cutaneous malignant, familial, CDK4 related NGS Genetic DNA Test.
Test Type and Doctor
The CDK4 Gene Melanoma Cutaneous Malignant Familial CDK4 Related Genetic Test falls under the category of cancer genetic testing. It is recommended to consult with an oncologist for this test.
Test Department
The CDK4 Gene Melanoma Cutaneous Malignant Familial CDK4 Related Genetic Test is conducted in our Genetics department.
Conclusion
The CDK4 Gene Melanoma Cutaneous Malignant Familial CDK4 Related Genetic Test is a valuable tool in identifying individuals at an increased risk of developing familial cutaneous malignant melanoma. It can provide crucial information for genetic counseling and guide personalized treatment options for affected individuals and their families.
| Test Name | CDK4 Gene Melanoma cutaneous malignant familial CDK4 related Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cancer |
| Doctor | Oncologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CDK4 Gene Melanoma, cutaneous malignant, familial, CDK4 related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CDK4 Gene Melanoma, cutaneous malignant, familial, CDK4 related NGS Genetic DNA Test gene CDK4 |
| Test Details | The CDK4 gene is a gene that codes for a protein called cyclin-dependent kinase 4, which plays a role in cell cycle regulation. Mutations in the CDK4 gene have been associated with an increased risk of developing cutaneous malignant melanoma, a type of skin cancer. Familial cutaneous malignant melanoma refers to cases where multiple family members are affected by the disease, suggesting a genetic predisposition. CDK4-related NGS genetic testing is a type of genetic test that can identify mutations or variations in the CDK4 gene that may increase the risk of developing familial cutaneous malignant melanoma. NGS stands for next-generation sequencing, which is a high-throughput DNA sequencing technology that can analyze multiple genes simultaneously. CDK4-related NGS genetic testing involves sequencing the CDK4 gene to identify any mutations or variations that may be present. This type of genetic testing can be useful in identifying individuals who may be at an increased risk of developing familial cutaneous malignant melanoma. It can also be helpful in providing information for genetic counseling and potentially guiding personalized treatment options for affected individuals and their families. |
